Theranostics 2020; 10(5):2402-2404. doi:10.7150/thno.43075 This issue

Erratum

Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system: Erratum

Siwen Li1, Yuxi Liu1, Yalan Rui1, Liping Tang2, Samuel Achilefu3, Yueqing Gu1,✉

1. Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, 24th Tong Jia street, Nanjing 210009, Jiangsu Province, China. Phone: 86-25-83271046; Fax: 86-25-83271046.
2. Department of Bioengineering, University of Texas at Arlington, Arlington, TX, USA.
3. Department of Radiology, School of Medicine, Washington University in St. Louis, MO, USA

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Li S, Liu Y, Rui Y, Tang L, Achilefu S, Gu Y. Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system: Erratum. Theranostics 2020; 10(5):2402-2404. doi:10.7150/thno.43075. Available from https://www.thno.org/v10p2402.htm

File import instruction

Corrected-article in Theranostics, Volume 8, 2621